ReviewMayo Clinic proceedings. Innovations, quality & outcomes2022

Evolution of Mineralocorticoid Receptor Antagonists in the Treatment of Chronic Kidney Disease Associated with Type 2 Diabetes Mellitus.

Jay B Wish et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.